ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Ultra納斯達克生物科
111.73
+1.96
1.79%
成交量：
5,274
成交額：
58.66萬
市值：
9,720.92萬
市盈率：
- -
高：
112.38
開：
110.00
低：
109.95
收：
109.77
52周最高：
126.40
52周最低：
55.34
股本：
87.00萬
流通股本：
87.00萬
量比：
0.36
換手率：
0.61%
股息：
0.32
股息率：
0.29%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標
路透中文
·
08/27
Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標
美股速递
·
08/27
歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態
美股速递
·
08/24
吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌
美股速递
·
08/24
美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。
智通财经
·
08/21
Piper Sandler上調安進目標價至457美元
格隆汇
·
08/21
美國研究綜述-安進、Analog Devices、莫德納
路透中文
·
08/20
福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？
TradingKey中文
·
08/20
吉利德科學(GILD)股票8月19日盤中上漲3.66%：背後推手曝光
TradingKey中文
·
08/20
安進(AMGN)股票8月19日盤中上漲3.19%：背後推手曝光
TradingKey中文
·
08/20
瑞穗上調安進目標價至352美元
格隆汇
·
08/19
駿利亨德森投資：專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦
智通财经网
·
08/19
藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」
蓝鲸财经
·
08/19
TScan Therapeutics披露：安進將終止與其研究合作及許可協議
美股速递
·
08/19
吉利德科學(GILD)股票8月18日盤中上漲3.14%：背後推手曝光
TradingKey中文
·
08/19
巴克萊上調安進目標價至380美元
格隆汇
·
08/17
Assembly股價上漲，因季度營收超出預期
路透中文
·
08/14
MacroGenics股價上漲，因吉利德支付了1000萬美元的里程碑款項
路透中文
·
08/12
數據簡報-全球製藥企業斥資數十億以擴大在美業務
路透中文
·
08/11
Tango因季度虧損額超出預期而股價下跌
路透中文
·
08/11
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BIB/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra納斯達克生物科","latestPrice":111.7347,"timestamp":1789416000000,"preClose":109.7741,"halted":0,"volume":5274,"delay":0,"changeRate":0.017860314955895785,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"盤前交易","change":1.9606,"latestTime":"09-15 05:05:58 EDT","open":110,"high":112.3799,"low":109.95,"amount":586601.7048,"amplitude":0.022135,"askPrice":115.39,"askSize":129,"bidPrice":108.21,"bidSize":5,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":111.7347,"sharesOutstanding":1040000,"nav":109.6885,"aum":95428995,"dividendRate":0.0029,"bidAskSpread":0.002634,"postHourTrading":{"tag":"盘后","latestPrice":111.22,"preClose":111.7347,"latestTime":"19:30 EDT","volume":432,"amount":48013.1882,"timestamp":1789428602354,"change":-0.5147,"changeRate":-0.004606,"amplitude":0.003311},"volumeRatio":0.3562598748884221,"impliedVol":0.4834,"impliedVolPercentile":0.752},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.3562598748884221,"shares":870000,"dividePrice":0.324,"high":112.3799,"amplitude":0.022135,"preClose":109.7741,"low":109.95,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":111.7347,"committee":-0.925373,"eps":0,"divideRate":0.0029,"volume":5274,"delay":0,"ttmEps":0,"open":110,"prevYearClose":79.7794,"prevWeekClose":109.7741,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":119.9993,"twentyDayClose":106.8706,"sixtyDayClose":84.9521},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662639773","title":"阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639773","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:08","pubTimestamp":1787810905,"startTime":"0","endTime":"0","summary":"阿斯利康的哮喘药物Tezspire在食管炎晚期临床试验中达到了所有目标路透8月27日-阿斯利康（AstraZeneca）AZN.L周四表示，其与安进（Amgen）AMGN.O联合开发的哮喘药物Tezspire，在治疗嗜酸性粒细胞性食管炎（一种食管的慢性炎症性疾病）的晚期临床试验中达到了主要和次要研究目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU0171276677.USD","LU0640478417.SGD","PBE","LU1196032939.SGD","LU0390134368.USD","TBXU","BBH","LU0158827948.USD","LU0211328371.USD","LU0757432116.USD","LU0496365809.HKD","BK4588","AMGN","IBB","LU0203345920.USD","PJP","LU1015430645.USD","LU1064927863.SGD","IE00B2B36J28.USD","BK4139","LU1481599808.USD","LU2089284900.SGD","BK5011","LU1273509221.SGD","LU0823416689.USD","LU0889565916.HKD","LU2237443549.SGD","LU0882574055.USD","LU2357627491.SGD","LU1989772840.SGD","LU0949170426.SGD","LU1061106388.HKD","LU1323610961.USD","LU0011850046.USD","03165","LU1119994496.HKD","IBBQ","LU2125909247.SGD","AZN.UK","LU0557290698.USD","LU0211327993.USD","BIB","LU1261432733.SGD","BK4599","LU0960981461.USD","LU0432979614.USD","LU1267930813.SGD","LU1923622614.USD","LU0526926950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146489142","title":"Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489142","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146489142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810443,"startTime":"0","endTime":"0","summary":"Tezspire在针对嗜酸性食管炎的III期临床试验中取得了令人瞩目的积极结果。该试验不仅成功达到了共同主要终点，而且所有关键次要终点也悉数告捷。Tezspire的优异表现，标志着该领域治疗可能迎来重大变革。共同主要终点的同时达成，以及关键次要终点的全面覆盖，充分验证了Tezspire的疗效一致性和临床获益的广泛性。业内专家指出，Tezspire的这项研究成果，不仅巩固了其在炎症性疾病治疗领域的地位，更可能为后续的监管审批和市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU0868494617.USD","BK4139","LU1571399168.USD","IE00BJT1NW94.SGD","TBXU","LU1983299246.USD","LU0289739699.SGD","BK4533","IE00BFTCPJ56.SGD","BBH","BIB","BK4534","IE00B4R5TH58.HKD","LU0122379950.USD","IE0002141913.USD","LU2089984988.USD","PBE","BK4566","IBB","BK4599","IBBQ","IE00B2B36J28.USD","LU0320765992.SGD","IE0009355771.USD","BK4585","SG9999001440.SGD","LU1057294990.SGD","LU0889565916.HKD","LU2112291526.USD","LU2242652126.USD","LU2242646821.SGD","BK4588","PJP","LU0109394709.USD","BK4581","LU0058720904.USD","LU2468319806.SGD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU1839511570.USD","GILD","LU1037948541.HKD","IE0002270589.USD","LU2357627491.SGD","LU2089984988.USD","LU1037948897.HKD","LU0889565916.HKD","BK4532","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1023059063.AUD","LU0058720904.USD","LU0823416689.USD","SG9999015945.SGD","LU2087621335.USD","BK4578","BK4585","LU0861579265.USD","TBXU","IE00B3T34201.USD","LU0859254822.USD","BBH","LU1430594728.SGD","LU1934455863.HKD","LU2324357040.USD","BK4139","IE00BSNM7G36.USD","LU0882574055.USD","LU1066051498.USD","LU0234570918.USD","IBBQ","IE00B7SZLL34.SGD","BK4583","BMED","LU2112291526.USD","BK4566","BIB","LU0965508806.USD","LU0965509101.SGD","BK4550","IE00B19Z3581.USD","LU1778281490.HKD","LU1057294990.SGD","LU1934455194.USD","LU1066053197.SGD","IE00BKVL7J92.USD","LU0109394709.USD","LU0965509010.AUD","SG9999015978.USD","LU0114720955.EUR","SG9999015952.SGD","IE00BZ1G4Q59.USD","BK4568","LU1674673428.USD","MEDI","IBB","LU0122379950.USD","BK4588","LU1571399168.USD","LU1585245621.USD","LU1934455277.USD","LU1674673691.USD","LU2468319806.SGD","SG9999015986.USD","TMED","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步，为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE0002270589.USD","BK4578","LU1430594728.SGD","LU0109394709.USD","LU0289739699.SGD","LU1585245621.USD","LU1934455194.USD","LU2468319806.SGD","SG9999015952.SGD","SG9999015986.USD","BMED","LU2089984988.USD","LU2357627491.SGD","LU1839511570.USD","BIB","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU2112291526.USD","IE00BKVL7J92.USD","LU1037948541.HKD","IE00B19Z3B42.SGD","BK4583","LU1061106388.HKD","LU0234570918.USD","BBH","LU0320765992.SGD","TBXU","LU1934455863.HKD","MEDI","BK4532","LU1934455277.USD","LU1674673428.USD","LU0859254822.USD","LU0882574055.USD","BK4585","LU1066053197.SGD","GILD","IBB","BK4568","TMED","BK4139","IBBQ","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1037948897.HKD","LU0823416689.USD","LU0965509283.SGD","LU1674673691.USD","LU0114720955.EUR","LU1023059063.AUD","LU1066051498.USD","LU0965509101.SGD","LU1571399168.USD","LU1057294990.SGD","IE00BSNM7G36.USD","LU0058720904.USD","BK4550","BK4566","LU1778281490.HKD","LU0122379950.USD","LU0861579265.USD","LU2087621335.USD","LU2324357040.USD","SG9999015945.SGD","IE00B19Z3581.USD","LU0965508806.USD","IE00B3T34201.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PJP","RSPT","DISC","LRGG","TBXU","QQMG","GXPC","EMQQ","BIB","BUYO","IXP","BBH","ARB","BCTK","MRGR","NBDS","ORCZ","FCOM","BWEB","TRUC","EVNT","ONEQ","FTC","WEBL","MSFX","HCA","MUSQ","PBE","GXPT","IBBQ","XLCI","JHMT","GOOX","IEME","IHF","IBB","PBS","MNA","TGRW","WEBX","CWC","AMGN","NBCC","TDAQ","JHCS","DRUP","MSFY","PNQI","KEMQ","GGTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBH","LU0320765992.SGD","LU2242652126.USD","IE0002141913.USD","BK4599","LU0109394709.USD","PJP","BK4534","BK4566","PBE","AMGN","LU1571399168.USD","BK4588","LU1061106388.HKD","LU0122379950.USD","LU1983299246.USD","LU1057294990.SGD","SG9999001440.SGD","IBB","LU2468319806.SGD","LU0058720904.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BIB","BK4533","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2112291526.USD","LU1023059063.AUD","TBXU","IBBQ","BK4139","LU0289739699.SGD","UDN","UUP","BK4581","LU2242646821.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四，华尔街证券分析师上调了多家在美国上市公司的评级和目标股价，其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLOU","IE00BJJMRZ35.SGD","LU1235294995.USD","LU1057294990.SGD","LU1670711040.USD","IYH","LU2506952170.USD","IE00BDGV0183.EUR","IGV","LU2298322129.HKD","LU1064131342.USD","MRNY","LU1815336760.USD","LU0058720904.USD","SG9999000418.SGD","IE00BZ9MQY76.HKD","WISE","SG9999001176.SGD","ABBV","LU2517655028.SGD","LU1551013425.SGD","IE000M9KFDE8.USD","SG9999014039.USD","IDNA","LU0068578508.USD","LU0965508806.USD","LU2023250843.SGD","LU2322448791.USD","LU0211327993.USD","BK4599","LU0912757837.SGD","LU2458330243.SGD","LU2237443549.SGD","LU1623119135.USD","FDTX","VHT","LU1169589451.USD","IE00B1BXHZ80.USD","BK4535","LU2242646821.SGD","LU2129689514.USD","IE000F7OJYX1.SGD","BK4550","LU0320765992.SGD","LU1861214812.USD","LU1150488218.USD","SG9999015986.USD","LU2461242641.AUD","LU0081259029.USD","LU0820561818.USD","MRNX","SG9999014021.USD","LU1941712264.USD","LU0256863811.USD","MRVX","LU1839511570.USD","LU1917777945.USD","IE00B3PB1722.GBP","LU1941712348.USD","BUG","LU0158827948.USD","IE0009356076.USD","LU1093756168.USD","LU2552382058.USD","LU0661504455.SGD","LU0985320562.USD","IE0004091025.USD","LU1989763005.USD","LU0256863902.USD","LU0122379950.USD","CRWC","BK4185","GTEK","LU0690374615.EUR","LU1732800096.USD","IE00B2B36J28.USD","LU2552382215.SGD","LU1720051017.SGD","LU2298321311.HKD","SNOU","LU0417517546.SGD","CLOD","BK4501","LU2357305700.SGD","PJP","LU2092937221.SGD","BK4533","LU0130517989.USD","TRUH","LU1291159041.SGD","LU2089985449.USD","SGXZ57979304.SGD","TJX","LU0950375773.USD","LU2487616109.SGD","LU1162221912.USD","LU1267930490.SGD","MEDX","ARTY","LU0127658192.USD","BK4534","SG9999014542.SGD","LU0310799852.SGD","LU0511384066.AUD","BK4528","LU2129689431.USD","LU2023250504.SGD","IE0002270589.USD","LU1823568750.SGD","LU1023059063.AUD","LU0823417737.USD","IE00BVYPNV92.GBP","IE000WAW04H5.SGD","CIBR","BK4558","BIB","LU1989771016.USD","LU1585245621.USD","BMED","LU2360106780.USD","LU0289739343.SGD","LU1037948897.HKD","IE00B5949003.HKD","LU0943347566.SGD","LU0868494617.USD","LU0545039389.USD","BK4505","LU1046421795.USD","LGHT","LU0795875169.SGD","LU1861220033.SGD","LU2272731600.USD","LU0109394709.USD","LU1852331112.SGD","LU2244417387.USD","SG9999011175.SGD","LU2106854487.HKD","LU2125909247.SGD","LU0289739699.SGD","PAWZ","IE00BLSP4452.SGD","LU0477156953.USD","MRVL","HRTS","LU2491050071.SGD","LU1803068979.SGD","LOW","LU2433249047.HKD","SG9999002232.USD","XDAT","LU2506951958.HKD","LU0124676726.USD","LU2360107325.USD","LU2272731865.HKD","LU0456855351.SGD","LU0823421416.USD","LU1066051498.USD","LU1074936037.SGD","LU2237438978.USD","LU2458330169.SGD","IE0009355771.USD","HAKY","LU0098860793.USD","SG9999002224.SGD","LU0070302665.USD","LU1244550494.USD","BK4130","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU1983299246.USD","LU1674673428.USD","LU2237443895.HKD","LU0689626769.HKD","LU1778281490.HKD","LU0965509101.SGD","SG9999001440.SGD","SG9999015952.SGD","LU0882574055.USD","FHLC","LU0861579265.USD","LU0395794307.EUR","IE00B19Z9Z06.USD","LU0238689110.USD","LU0823434740.USD","LU0476273544.USD","IE00BBT3K403.USD","MRVU","IE00BMPRXN33.USD","LU1169590202.USD","LU2265009873.SGD","XLV","LU2361044865.SGD","MVLL","BK4566","WDAY","LU2264538146.SGD","SG9999013999.USD","IE00BD6J9T35.USD","IE0004086264.USD","SG9999014005.SGD","IE000BZT7R73.USD","IE00B19Z9P08.USD","LU2404859667.USD","TBXU","LU0289961442.SGD","LU0642271901.SGD","BK4605","LU1934455277.USD","FAI","LU2404859741.USD","LU0077335932.USD","LU2098885051.SGD","LU0868494708.USD","EL","SNOY","SG9999015978.USD","LU1934455194.USD","LU2023251221.USD","LU2089283258.USD","BK4548","PBE","LU0689472784.USD","LU0444971666.USD","SNOW","LU0823434583.USD","LU1003077747.HKD","SG9999015341.SGD","LU2517655291.USD","MRNA","LU1861219969.SGD","BK4592","LU0965509283.SGD","LU1316542783.SGD","LU1935042991.SGD","LU0859254822.USD","IHF","LU0052756011.USD","LU2237443382.USD","IE0034235188.USD","IE0000B7K699.USD","LU2361044949.HKD","LU0130102774.USD","LU0211331839.USD","LU1989772840.SGD","BBH","LU1496350171.SGD","LU2286300806.USD","LU0823417653.USD","LU0889565833.HKD","LU1571399168.USD","LU2360107168.USD","LU1267930573.SGD","LU1992135399.USD","BK4504","WDNA","GLAM","LU1244550577.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0128525929.USD","BK4598","LU2125909916.SGD","BK4581","LU2211815571.USD","LU1066051225.USD","BK4585","IE00BMPRXQ63.HKD","MRK","BK4516","IE000MB6IJN5.SGD","BK4588","SG9999015945.SGD","LU0094547139.USD","LU1974910355.USD","LU2355687059.USD","BILL","LU0302445910.USD","LU2133065610.SGD","LU0949170772.SGD","LU2517655374.HKD","LU1430594728.SGD","LU0198837287.USD","JDOC","LU1084165304.USD","LU0265550946.USD","SPAM","LU1496350502.SGD","BK4613","LU2125909593.SGD","FXL","LU1712237335.SGD","LU0234570918.USD","LU0310800965.SGD","IBB","LU2041044095.USD","LU0444973449.USD","LU1116320901.HKD","LU0154236417.USD","LU1670711123.USD","LU0965509010.AUD","LU1929549753.HKD","SG9999001176.USD","HCA","IE00BN8TJ469.HKD","LU0128525689.USD","LU0310800379.SGD","LU1923623000.USD","LU2087621335.USD","ADI","LU0726765562.USD","LU2360032135.SGD","IE00BZ199S13.USD","IE00B4R5TH58.HKD","XNTK","BK4007","LU1037948541.HKD","FTXL","LU0320765489.SGD","LU1244550221.USD","LU0820561909.HKD","IE0004445239.USD","LU1951200564.SGD","SG9999003800.SGD","SG9999014567.USD","BK4097","LU0211328371.USD","LU0029864427.USD","LU0320765646.SGD","LU0097036916.USD","IE00B775SV38.USD","LU1303367103.USD","LU2242652126.USD","IXJ","LU0690374961.EUR","BK4560","LU0265550359.USD","LU0957808578.USD","IE000SO60NU8.SGD","WCBR","BK4139","LU0553294199.USD","BK4515","GNOM","LU2129689605.HKD","LU1720051108.HKD","IE00B19Z3581.USD","BK4596","IE00BGHQF631.EUR","BK4116","LU2506951875.HKD","IE00BLSP4239.USD","LU1267930227.SGD","LU0170899867.USD","AIFD","SMHX","04332","SG9999014559.SGD","LU1923622291.USD","SG9999014575.USD","LU1066053197.SGD","LU0203347892.USD","LU2357627491.SGD","LU1093756325.SGD","BK4083","LU1923622614.USD","LU0433182093.SGD","LU1804176565.USD","AIS","LU1978683503.SGD","IE00BMPRXR70.SGD","LU0889565916.HKD","LU2250418816.HKD","CRWD","BK4094","BK4597","IE00B5TLWC47.USD","AGNG","LU1699723380.USD","TGT","LU0069063385.USD","LU1992135472.HKD","LU2506952097.USD","LU1061106388.HKD","LU2468319806.SGD","BK4551","LU1989764664.SGD","PCTY","LU1261432733.SGD","LU2552382132.HKD","LU0724618433.USD","BK4503","BK4141","LU0208291251.USD","LU1035773651.USD","LU1691799644.USD","LU0878866978.SGD","SG9999015358.SGD","LU0823421333.USD","DTCR","LU0985489474.SGD","LU0053666078.USD","PSWD","LU1989764748.USD","LU1670710588.SGD","LU1861215975.USD","LU0648001328.SGD","LU0114720955.EUR","LU2237443465.HKD","LU2275660780.HKD","QQQA","LU0312595415.SGD","LU1551013342.USD","IE00BVYPNW00.USD","LU0234572021.USD","GDOC","BK4512","IBBQ","IE00B42XCP33.USD","LU1150488135.SGD","LU1670627923.USD","LU2237443978.SGD","LU1201861249.SGD","IE00B894F039.SGD","LU0708994859.HKD","LU0203345920.USD","BK4155","BK4607","LU1066051811.HKD","BK4559","LU1674673691.USD","WUGI","LU2324357040.USD","LU2347655073.USD","LU1642822529.SGD","LU0056508442.USD","BK4543","LU0795875086.SGD","LU0823411888.USD","LU0823416689.USD","LU2473716301.USD","RXL","LU1489326972.SGD","BK4023","LU1670628061.USD","LU1951198990.SGD","LU0432979614.USD","IE00B3S45H60.SGD","LU2125154935.USD","LU0187121727.USD","LU2931357623.SGD","BK4554","LU2543165471.USD","LU1718418525.SGD","LU2125154778.USD","LU0109392836.USD","LU2089284900.SGD","LU0274383776.USD","CRWL","LU2089984988.USD","LU0124384867.USD","LU1732799900.SGD","LU0106261372.USD","LU1935043536.SGD","BK4532","LU0082616367.USD","LU2361045086.USD","LU0266013472.USD","LU0057025933.USD","WOLF","LU1069347547.HKD","LU1116320737.USD","LU1988902786.USD","LU2112291526.USD","LU0314106906.USD","LU0006306889.USD","LU1506573853.SGD","LU2272731782.SGD","DAT","LU1548497426.USD","LU1989773731.SGD","LU2322448957.HKD","LU1989772923.USD","LU0210528500.USD","BK4568","IHE","IE00BKVL7J92.USD","LU2491050154.USD","LU1670710661.SGD","LU2360108059.USD","LU1934455863.HKD","LU0472753341.HKD","LU0719512351.SGD","SG9999014013.SGD","AIPI","LU2347655156.SGD","PPH","LU0314104364.USD","LU2290526834.HKD","IE0002141913.USD","FTXH","BK4561","LU0786609619.USD","BK4183","AMGN","SOXY","IE00B19Z3B42.SGD","LU2491049909.HKD","LU2125909759.SGD","LU0942090050.USD","LU1119994496.HKD","BK4604","LU0980610538.SGD","IE00BZ1G4Q59.USD","BK4114","LU0738911758.USD","LU2237443622.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后，福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期，公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级，平均目标价达 563.25 美元。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU2456880835.USD","BK4567","LU1674673428.USD","LU0079474960.USD","LU2462157665.USD","IBB","GNMX","SG9999001176.SGD","LU0320765992.SGD","LU0432979614.USD","BK4588","IBBQ","LU1778281490.HKD","LU2236285917.USD","LU2362541273.HKD","LU1585245621.USD","IE00B19Z3581.USD","LU0823416689.USD","LU0417517546.SGD","LU1069344957.HKD","IE00B4R5TH58.HKD","TBXU","LU0289739699.SGD","IDNA","VRTX","LU1674673691.USD","LU2362541513.USD","IE0002270589.USD","IE00B19Z9Z06.USD","LU0109394709.USD","LU2237438978.USD","BBH","PBE","BIB","LU0058720904.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU1093756325.SGD","SGXZ57979304.SGD","LU1035775433.USD","LU2468319806.SGD","LU0256863811.USD","BK4532","IE0009355771.USD","IE00B19Z9P08.USD","BK4139","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660113478","title":"吉利德科學(GILD)股票8月19日盤中上漲3.66%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660113478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660113478?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 03:17","pubTimestamp":1787167048,"startTime":"0","endTime":"0","summary":"• 得益于HIV产品组合增长加速，吉利德上调了全年销售指引。\n• 联邦法院颁布禁令阻止海外进口，以保护其核心市场份额。\n• 分析师给予“买入”评级，平均目标价为157.79美元。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118864-market-movers-gild-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","IE00BKVL7J92.USD","SG9999015978.USD","LU0320765992.SGD","LU1674673428.USD","LU2468319806.SGD","BMED","BK4578","GILD","IE00B19Z3B42.SGD","IBBQ","LU1934455277.USD","LU1066051498.USD","LU1934455863.HKD","BK4568","IBB","LU0965508806.USD","SG9999015952.SGD","BK4588","SG9999015945.SGD","LU1057294990.SGD","LU2324357040.USD","BK4583","IE0002270589.USD","LU1674673691.USD","IE00B19Z3581.USD","BK4532","BBH","LU0289739699.SGD","LU1037948541.HKD","IE00BZ1G4Q59.USD","LU0058720904.USD","BIB","LU1839511570.USD","BK4550","IE00B7SZLL34.SGD","LU0823416689.USD","LU0965509283.SGD","LU0965509101.SGD","SG9999015986.USD","TMED","LU1023059063.AUD","LU0234570918.USD","LU1934455194.USD","BK4139","LU1585245621.USD","LU1778281490.HKD","TBXU","IE00BSNM7G36.USD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819420","title":"安進(AMGN)股票8月19日盤中上漲3.19%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819420","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:16","pubTimestamp":1787163383,"startTime":"0","endTime":"0","summary":"• Argus上调安进目标价，并重申“买入”评级。\n• 第二季度财务业绩超出华尔街的营收和盈利预期。\n• 技术指标显示 MACD 买入信号及 RSI 买入条件。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118749-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU0868494617.USD","BK4139","LU1571399168.USD","IE00BJT1NW94.SGD","TBXU","LU1983299246.USD","LU0289739699.SGD","BK4533","IE00BFTCPJ56.SGD","BBH","BIB","BK4534","IE00B4R5TH58.HKD","LU0122379950.USD","IE0002141913.USD","LU2089984988.USD","PBE","BK4566","IBB","BK4599","IBBQ","IE00B2B36J28.USD","LU0320765992.SGD","IE0009355771.USD","BK4585","SG9999001440.SGD","LU1057294990.SGD","LU0889565916.HKD","LU2112291526.USD","LU2242652126.USD","LU2242646821.SGD","BK4588","PJP","LU0109394709.USD","BK4581","LU0058720904.USD","LU2468319806.SGD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660585446","title":"瑞穗上調安進目標價至352美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660585446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660585446?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:55","pubTimestamp":1787129710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4534","IBBQ","LU0109394709.USD","LU0058720904.USD","PBE","LU0889565916.HKD","UDN","LU0122379950.USD","LU2089984988.USD","BBH","BK4585","LU0289739699.SGD","BK4581","IE0009355771.USD","LU1983299246.USD","IBB","LU1057294990.SGD","LU1061106388.HKD","BK4139","UUP","IE00B4R5TH58.HKD","PJP","LU2112291526.USD","LU1571399168.USD","LU2242646821.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0868494617.USD","BK4533","IE00B2B36J28.USD","BK4588","LU2242652126.USD","SG9999001440.SGD","BK4599","TBXU","IE0002141913.USD","AMGN","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"駿利亨德森投資：專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431564?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称，尽管利率较市场年初的预期为高，但生物科技行业交易活动的增长动力持续不减。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","IWO","JDOC","MRNY","BIS","IBB","SPCK","FBT","MRNX","IJT","BK4588","BIB","PBE","BK4582","GTPE","BBP","IBBJ","IYG","BBC","QSML","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416851","title":"藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416851","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660416851?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 09:48","pubTimestamp":1787104101,"startTime":"0","endTime":"0","summary":"湘雅二医院方面向澎湃新闻表示，院方确有发该“协办函”。据此次公布的协办函，对几家涉事药企的处理决定颇为严厉。近年来，医药代表违规已不仅是行业道德问题，而是监管重点。此次湘雅二医院将企业列入购销负面清单，正是医院端落地上述政策的缩影。湘雅二医院相关负责人表示，自国家在2020年底建立医药代表备案制度，医院就积极响应国家政策，并不断完善内部制度和执行流程。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787103396417327872","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IBB","BK4588","BK4581","LU0320765992.SGD","AMGN","LU2242646821.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","LU1571399168.USD","LU0109394709.USD","LU2242652126.USD","BK4534","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","BBH","LU2089984988.USD","BK4566","LU2468319806.SGD","LU1057294990.SGD","688578","BK4533","BK0239","TBXU","BIB","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4599","LU0889565916.HKD","IE0009355771.USD","BK4585","PJP","LU1983299246.USD","IBBQ","IE00B2B36J28.USD","LU0868494617.USD","SG9999001440.SGD","IE0002141913.USD","LU0122379950.USD","LU1061106388.HKD","PBE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192416297","title":"TScan Therapeutics披露：安進將終止與其研究合作及許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1192416297","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192416297?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 05:04","pubTimestamp":1787087050,"startTime":"0","endTime":"0","summary":"值得注意的是，安进作为全球领先的生物制药公司，此举无疑将对TScan Therapeutics的研发管线及未来战略布局产生深远影响。TScan Therapeutics方面表示，将仔细评估这一变化对公司在研项目及整体运营带来的潜在影响。对于TScan Therapeutics而言，此番变故或许意味着需要重新校准其研发路径，并探索新的合作机会或资金来源以继续推进其创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4588","BK4566","LU2242646821.SGD","IE00BJJMRZ35.SGD","AMGN","IE00BFTCPJ56.SGD","PBE","BK4534","LU0289739699.SGD","LU1571399168.USD","SG9999001440.SGD","LU0868494617.USD","LU1023059063.AUD","IE0009355771.USD","LU2089984988.USD","LU1057294990.SGD","LU0109394709.USD","BK4533","IE0002141913.USD","BK4599","LU2112291526.USD","TBXU","LU2242652126.USD","LU2468319806.SGD","IBB","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4139","PJP","BK4539","BIB","IBBQ","BK4581","LU1983299246.USD","TCRX","LU0122379950.USD","BK4585","LU0058720904.USD","BBH","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491619","title":"吉利德科學(GILD)股票8月18日盤中上漲3.14%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491619","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491619?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 02:16","pubTimestamp":1787076999,"startTime":"0","endTime":"0","summary":"• 联邦法院禁令阻止了吉利德关键HIV药物的海外进口。\n• 强劲的基础业务营收增长与上调业绩指引提振了市场乐观情绪。\n• 肿瘤领域的战略投资及机构看涨期权活动的活跃支撑了股价的上涨势头。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262115765-market-movers-gild-20260818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","IBB","MEDI","SG9999015952.SGD","GILD","LU1061106388.HKD","LU1934455863.HKD","BK4532","LU1023059063.AUD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU0965509101.SGD","LU2324357040.USD","IE00B7SZLL34.SGD","LU0965508806.USD","BK4583","LU1037948897.HKD","TBXU","LU0320765992.SGD","LU1430594728.SGD","LU0289739699.SGD","LU0109394709.USD","LU1037948541.HKD","SG9999015978.USD","IE00B19Z3581.USD","SG9999015986.USD","BMED","LU0114720955.EUR","BK4585","LU1066053197.SGD","LU1778281490.HKD","IE00BZ1G4Q59.USD","BK4566","LU1674673428.USD","IE00B3T34201.USD","LU2112291526.USD","LU1674673691.USD","BK4578","LU2089984988.USD","BIB","LU0823416689.USD","IBBQ","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1839511570.USD","LU1571399168.USD","BBH","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101358","title":"巴克萊上調安進目標價至380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101358","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101358?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 11:05","pubTimestamp":1786935953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0889565916.HKD","LU0109394709.USD","AMGN","IE00B4R5TH58.HKD","LU0122379950.USD","LU1571399168.USD","PBE","LU2112291526.USD","BK4533","LU0058720904.USD","LU2468319806.SGD","UUP","LU2089984988.USD","PJP","BK4588","IBB","LU0320765992.SGD","LU1057294990.SGD","UDN","LU2242652126.USD","LU0289739699.SGD","LU0868494617.USD","LU1061106388.HKD","BK4581","SG9999001440.SGD","TBXU","IE00BFTCPJ56.SGD","BK4566","LU1983299246.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4139","LU2242646821.SGD","BBH","BIB","IBBQ","IE00B2B36J28.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4599","BK4534","BK4585","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659400001","title":"Assembly股價上漲，因季度營收超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2659400001","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659400001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 23:25","pubTimestamp":1786721141,"startTime":"0","endTime":"0","summary":"BUZZ-Assembly股价上涨，因季度营收超出预期8月14日-** 药物研发公司Assembly Biosciences（ASMB.O）股价上涨4.6%，报31.32美元** ASMB第二季度与吉利德（GILD.O）合作研究的收入为1340万美元，高于去年同期的960万美元** 据LSEG数据显示，分析师此前平均预期营收为860万美元** 公司表示，营收增长包括针对吉利德合作项目下未来活动最新预估所作的510万美元补足调整** 报告显示第二季度每股亏损20美分，而市场预期为每股亏损65美分** 计入当日涨幅后，该股年初至今累计上涨11.8%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL4S44B103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","BK4583","LU0058720904.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU0965509101.SGD","IE00BSNM7G36.USD","BBH","LU2112291526.USD","LU0965508806.USD","LU1061106388.HKD","BK4566","LU2468319806.SGD","SG9999015952.SGD","LU0861579265.USD","LU1037948541.HKD","LU2324357040.USD","LU1839511570.USD","LU0889565916.HKD","LU2087621335.USD","ASMB","LU1066051498.USD","BK4585","LU0114720955.EUR","MEDI","IE00B19Z3581.USD","TBXU","BK4532","LU1037948897.HKD","SG9999015945.SGD","LU0234570918.USD","GILD","IBBQ","IE00B3T34201.USD","LU1934455277.USD","SG9999015986.USD","LU1066053197.SGD","BK4139","BK4568","IBB","LU0122379950.USD","LU0289739699.SGD","LU0965509283.SGD","LU0109394709.USD","TMED","BK4588","IE00B19Z3B42.SGD","BK4578","BIB","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658465479","title":"MacroGenics股價上漲，因吉利德支付了1000萬美元的里程碑款項","url":"https://stock-news.laohu8.com/highlight/detail?id=2658465479","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658465479?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 05:18","pubTimestamp":1786483082,"startTime":"0","endTime":"0","summary":"BUZZ-MacroGenics股价上涨，因吉利德支付了1000万美元的里程碑款项8月11日-** 药物开发商MacroGenics（MGNX.O）的股价在盘后交易中上涨3.8%，至4.07美元** 该公司表示，根据其与吉利德（GILD.O）就一项临床前双特异性项目（一种癌症疗法）达成的许可协议，已收到1000万美元的里程碑付款** 根据2022年签署的合作协议，MacroGenics与吉利德正在推进三个项目：处于临床阶段的抗癌疗法MGD024，以及两个处于临床前阶段的双特异性项目** MGNX仍有资格获得最高约16亿美元的额外开发、监管及商业里程碑付款** 今年以来，该公司股价已翻了一番多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S4481IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","MEDI","LU0965508806.USD","LU1066051498.USD","BK4566","LU1430594728.SGD","IE00B7SZLL34.SGD","LU1571399168.USD","LU2468319806.SGD","BK4139","BK4578","BMED","LU1778281490.HKD","BIB","LU2087621335.USD","LU1674673428.USD","BK4532","BBH","LU1585245621.USD","LU1934455863.HKD","IBB","MGNX","IE00BKVL7J92.USD","LU0114720955.EUR","LU0965509101.SGD","LU1023059063.AUD","LU0234570918.USD","LU0058720904.USD","GILD","BK4585","LU0882574055.USD","SG9999015986.USD","SG9999015978.USD","IE00BZ1G4Q59.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU1839511570.USD","LU1934455277.USD","LU2089984988.USD","SG9999015952.SGD","LU1674673691.USD","LU2324357040.USD","IE0002270589.USD","IE00BSNM7G36.USD","BK4550","TBXU","IBBQ","SG9999015945.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658591102","title":"數據簡報-全球製藥企業斥資數十億以擴大在美業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2658591102","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658591102?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:59","pubTimestamp":1786463961,"startTime":"0","endTime":"0","summary":"数据简报-全球制药企业斥资数十亿以扩大在美业务更新了第18段中关于百健生产工厂的数据路透8月11日-全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔投资约10亿美元，以加强其眼科护理业务在美国的制造能力。这家制药公司宣布将投资 6.5 亿美元 ，以扩大其位于波多黎各洪科斯工厂的药品生产规模，此举预计将创造近 750 个就业岗位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S448167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","LU1941712348.USD","LU2491050071.SGD","LU1032466523.USD","GB00BDT5M118.USD","IE00B3T34201.USD","LU2129689514.USD","LU1506573853.SGD","BIIB","MHIP","LU0882574055.USD","LU1988902786.USD","SG9999015358.SGD","SGXZ99366536.SGD","MEDX","SG9999015952.SGD","IE0004445015.USD","LU1585245621.USD","LU2211815571.USD","LU0823434740.USD","LU0942090050.USD","BK4581","IE00B3PB1722.GBP","SG9999015978.USD","LU0124676726.USD","LU2023250330.USD","LU1629891620.HKD","SGXZ80539844.SGD","IE00BBT3K403.USD","LU0053666078.USD","LU2237438978.USD","LU0868494708.USD","LU1430594728.SGD","LU1974910355.USD","LU2430703251.USD","IE000MB6IJN5.SGD","LU2596442595.SGD","LU0980610538.SGD","LU1069344957.HKD","LU2491050154.USD","LU2089284900.SGD","IBB","BK4007","IE00BJJMRY28.SGD","LU2168564222.USD","IE00BK4W5L77.USD","LU0208291251.USD","LU0965509283.SGD","LU1868836591.USD","LU1917777945.USD","LU2357627491.SGD","LU2552382058.USD","LU1699723380.USD","LU0320765646.SGD","LU0820561909.HKD","LU2063271972.USD","LU2750360997.AUD","LU0057025933.USD","LU1064131342.USD","LU2491049909.HKD","LU0098860793.USD","LU1712237335.SGD","LU0256863902.USD","LU2360106947.USD","LU0210528500.USD","LU1116320901.HKD","BK4592","LU0079474960.USD","LU0238689110.USD","LU2111349929.HKD","LU0203345920.USD","LU0006306889.USD","LU0994945656.USD","LU0158827781.USD","LU2433249047.HKD","BK4559","SG9999013999.USD","LU1670711040.USD","LLYZ","LU1244550494.USD","SG9999011175.SGD","IE00B775H168.HKD","LU0432979614.USD","LU0477156953.USD","LU2456880835.USD","SG9999001176.USD","FHLC","IE00B19Z3581.USD","LU1267930730.SGD","LU2112291526.USD","LU0320765059.SGD","LU0786609619.USD","BK4532","LU1035775433.USD","LU1979441026.SGD","LU1496350502.SGD","IE00BKDWB100.SGD","IE0000B7K699.USD","LU0122379950.USD","LU1778281490.HKD","LU1366192091.USD","IE00BFXG1179.USD","LU2756315318.SGD","LU0237698245.USD","LU1720051108.HKD","LU1551013425.SGD","AMGN","BMED","IE00BJT1NW94.SGD","LU0672654240.SGD","LU1023059063.AUD","LU1983299246.USD","LU2264538146.SGD","LU1323610961.USD","LU0114720955.EUR","LU0456855351.SGD","LU0965509010.AUD","LU0211327993.USD","LU0321505439.SGD","LU2461242641.AUD","BK4533","LU0964807845.USD","IE00BZ1G4Q59.USD","SG9999014542.SGD","LU2347655073.USD","LU0738911758.USD","IE0002141913.USD","LU2237443622.USD","LU2265009873.SGD","LU0912757837.SGD","IE000F7OJYX1.SGD","TBXU","MEDI","LU0133085943.USD","LU0466842654.USD","LU2023250843.SGD","XLV","LU1934455194.USD","LU0320765489.SGD","LU0211328371.USD","IE0002270589.USD","LU2430703095.HKD","LU0106261372.USD","LU2756315664.SGD","LU2087625088.SGD","LU2125154935.USD","LU0648001328.SGD","IE00BLSP4452.SGD","LU0689626769.HKD","LU0203202063.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","PFE","HRTS","LU2552382215.SGD","LU1121112475.USD","LU0310799852.SGD","IE00BN8TJ469.HKD","IE0001KFT4U8.USD","LU1069347547.HKD","LU1894683348.USD","IE00BGHQF631.EUR","CURE","LU2357305700.SGD","IE00BDGV0183.EUR","LU0162691827.USD","IE00B42XCP33.USD","IE0005OL40V9.USD","SG9999015945.SGD","IBBQ","LU1221951129.SGD","LU0234570918.USD","LU1261432733.SGD","LU2505996681.GBP","IE00BLSP4239.USD","LU1674673691.USD","LU1267930573.SGD","SG9999014559.SGD","LU0661504455.SGD","LU1670628061.USD","LU1935042991.SGD","LU1670710588.SGD","LU2023250504.SGD","AZNH","TRUH","LU2468319806.SGD","SG9999002224.SGD","GLAM","IE00B19Z9Z06.USD","LU2242646821.SGD","BK4504","SG9999002232.USD","LU0345769128.USD","LU0265550359.USD","LU1623119135.USD","SGXZ51526630.SGD","LU1093756325.SGD","LU1232071149.USD","LU0868494617.USD","LU1228905037.USD","LU0225283273.USD","IE00BKVL7J92.USD","LU2746668461.USD","JDOC","LU0072461881.USD","BK7501","LU2168563687.JPY","LU2417539215.USD","BK4534","IE00B1XK9C88.USD","LU0820562030.AUD","LU1868836914.USD","SG9999015986.USD","LU1934455863.HKD","LU0882574139.USD","IE000WAW04H5.SGD","LU2125909247.SGD","LU2602419157.SGD","LU1127390331.HKD","LU0306807586.USD","LU1066051811.HKD","SGXZ31699556.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU1061106388.HKD","LU1066053197.SGD","VHT","LU1291159041.SGD","BK4566","LU1868836757.USD","LU0859254822.USD","LU1883839398.USD","BK4599","LU0471298694.HKD","GDOC","LU0708995401.HKD","TMED","LU2360032135.SGD","LU0385154629.USD","LU0726765562.USD","IE0034235303.USD","LU0795875086.SGD","LU2471134523.USD","LU0097036916.USD","IE00B19Z9P08.USD","IE000M9KFDE8.USD","WDNA","LU0426417589.USD","LU0708994859.HKD","LU2168564065.EUR","LU0058720904.USD","LU2125909593.SGD","LU2505996509.AUD","BK4139","LU1804176565.USD","SG9999003800.SGD","LLY","LU0395794307.EUR","LU2237443978.SGD","IE00BN29S564.USD","LU1280957306.USD","LU2129689605.HKD","SGXZ81514606.USD","LU1496350171.SGD","IE00BFSS8Q28.SGD","LU1720051017.SGD","LU2168564495.EUR","FTXH","LU2213496289.HKD","LU1670710661.SGD","LU0417517546.SGD","LU0234572021.USD","PJP","LU0174119429.USD","LU0289739343.SGD","LU0128525929.USD","IE00BJLML261.HKD","LU0354030511.USD","LU2237443465.HKD","LU1548497426.USD","LU1923622614.USD","LU1868837136.USD","BIB","IE00B19Z3B42.SGD","LU0965509101.SGD","ELIS","BMY","IE00BVYPNW00.USD","LU1196500208.SGD","LU1043141396.HKD","LU2324357040.USD","IE00B2B36J28.USD","IE00B7KXQ091.USD","LU2361044949.HKD","RXL","CANC","LU0265550946.USD","IE00BFSS7M15.SGD","BK4568","AZN","LU1718418525.SGD","LU1941712264.USD","LU0861579265.USD","LU2237443549.SGD","LU0943347566.SGD","LU1057294990.SGD","LU0640476718.USD","LU1244550577.SGD","LU2087621335.USD","LU1732799900.SGD","IHE","LU2361045086.USD","LU1670627923.USD","LU1145028129.USD","LLII","LU0792757196.USD","LU0170899867.USD","LU1674673428.USD","BBH","LU0545039389.USD","BK4588","BK7067","LU0345770993.USD","LU0029864427.USD","IE000SO60NU8.SGD","LU0787776722.HKD","LU2592432038.USD","LU0472753341.HKD","LU0683600562.USD","LU1162221912.USD","LU0198837287.USD","LU0553294199.USD","LU0965508806.USD","LU2108987350.USD","LU0109391861.USD","LU0471298777.SGD","LU2237443382.USD","BK4550","LU0889566641.SGD","LU0345770308.USD","IE00BVYPNV92.GBP","ELIL","LU1914381329.SGD","LU2089984988.USD","PPH","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0130517989.USD","IYH","IE00B894F039.SGD","IE00BWXC8680.SGD","LLYX","LU0985320562.USD","04332","LU2896262040.SGD","SG9999014898.SGD","LU1066051498.USD","LU0225284248.USD","SG9999014567.USD","LU1066051225.USD","LU1035773651.USD","SG9999015341.SGD","LU1221951046.USD","BK4578","IE00BK4W5M84.HKD","LU1032955483.USD","LU2237443895.HKD","LU1116320737.USD","LU2462157665.USD","LU2129689431.USD","LU0203201768.USD","LU2487616109.SGD","LU1989771016.USD","LU0823434583.USD","LU0096364046.USD","LU1571399168.USD","LU2403377893.USD","BK4583","BK7511","LU0949170772.SGD","LU0210536198.USD","LU1201861249.SGD","LU0316494557.USD","SG9999017495.SGD","LU0266013472.USD","LU0256863811.USD","LU2089283258.USD","BK4516","LU2028103732.USD","IE0004445239.USD","GILD","LU0985481810.HKD","LU1839511570.USD","LU0689472784.USD","LU1267930813.SGD","ABBV","LU0211331839.USD","LU2746668974.SGD","LU1829250122.USD","LU0354030438.USD","LU2106854487.HKD","OZEM","LU1868837300.USD","LU0306806265.USD","LU1003077747.HKD","LU1732800096.USD","PBE","LU0353189763.USD","SG9999014880.SGD","IXJ","LU0889565916.HKD","LU2430703178.SGD","LU2750360641.GBP","LU2361044865.SGD","LU1093756168.USD","LU0070217475.USD","LU0069063385.USD","LU0353189680.USD","LU0070302665.USD","THNR","AGNG","IE00BSNM7G36.USD","LU0820561818.USD","LU2125154778.USD","LU0795875169.SGD","LU0158827948.USD","LU1228905540.USD","SG9999001440.SGD","IE00BKPKM429.USD","LU1894683264.USD","LU0823416689.USD","SG9999014906.USD","IE0009355771.USD","LU2471134952.CNY","BK4585","LU1934455277.USD","LU2471134796.USD","LU0323591593.USD","LU0310800379.SGD","LU1244550221.USD","LU2242652126.USD","LU1059921491.USD","LU2023251221.USD","LU0109394709.USD","SG9999018857.SGD","IE000BZT7R73.USD","LU2552382132.HKD","LU2168564149.EUR","CSL.AU","LU2236285917.USD","LU2133065610.SGD","LU1989772923.USD","SG9999018865.SGD","LU0289961442.SGD","LU2471134879.HKD","PAWZ","LU1989772840.SGD","IE00B7SZLL34.SGD","LU0130102774.USD","LU1074936037.SGD","LU2347655156.SGD","LU1551013342.USD","LU1043141123.HKD","IE00BJJMRX11.SGD","LU1670711123.USD","SG9999014575.USD","IE00B1BXHZ80.USD","LU0511384066.AUD","LU0225771236.USD","LU1037948541.HKD","MRK","IE00B4JS1V06.HKD","LU2462591350.SGD","LU0320765992.SGD","LU1267930490.SGD","ILDR","LU1929549753.HKD","LU0094547139.USD","SG9999014914.USD","LU0426412945.USD","LU1814569148.SGD","LU1037948897.HKD","LU0545562505.USD","LU2271345857.HKD","SGXZ57979304.SGD","LU0345769631.USD","JNJ","LU0321505868.SGD","LU0267386448.USD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658391156","title":"Tango因季度虧損額超出預期而股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2658391156","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658391156?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:19","pubTimestamp":1786461555,"startTime":"0","endTime":"0","summary":"BUZZ-Tango因季度亏损额超出预期而股价下跌8月11日-** 药物研发公司Tango TherapeuticsTNGX.O股价下跌3.3%，报26.75美元** 据LSEG数据显示，该公司报告第二季度每股亏损37美分，而分析师平均预期为每股亏损31美分** TNGX报告称，截至2026年6月30日的三个月内未产生合作收入，原因是与吉利德GILD.O的合作关系及研发活动已终止** 该公司202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4T44814U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","TNGX","BK4585","IDNA","LU0889565916.HKD","LU0114720955.EUR","BIB","BK4532","IE00BJJMRZ35.SGD","LU1778281490.HKD","LU2468319806.SGD","IE0002270589.USD","TMED","IE00BZ1G4Q59.USD","BK4588","LU1037948897.HKD","LU2089984988.USD","MEDI","IE00B2B36J28.USD","LU1674673428.USD","LU2087621335.USD","LU0861579265.USD","IE00B4R5TH58.HKD","LU1066051498.USD","IE00B19Z3581.USD","LU1934455277.USD","LU0109394709.USD","BK4583","SG9999015952.SGD","CANC","LU0320765992.SGD","IBB","GILD","IE00BJT1NW94.SGD","BBH","IE00B7SZLL34.SGD","LU0965508806.USD","RVMD","LU1066053197.SGD","BK4139","LU2324357040.USD","LU0965509010.AUD","LU0289739699.SGD","TBXU","LU1674673691.USD","IE0009355771.USD","LU0234570918.USD","LU1934455863.HKD","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":142,"code":"91000000","status":"200"}]}}